ADAM-17: a novel therapeutic target for triple negative breast cancer (vol 24, pg 362, 2013)

被引：0
|
作者：
McGowan, P. M.
机构：
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷 / 08期
关键词：
D O I：
10.1093/annonc/mdt285
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2199 / 2199
页数：1
相关论文
共 50 条
  • [21] Ganglioside GD2: a novel therapeutic target in triple-negative breast cancer
    Shao, Claire
    Anand, Vivek
    Andreeff, Michael
    Battula, Venkata Lokesh
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2022, 1508 (01) : 35 - 53
  • [22] CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
    Ring, Alexander
    Cu Nguyen
    Smbatyan, Goar
    Tripathy, Debu
    Yu, Min
    Press, Michael
    Kahn, Michael
    Lang, Julie E.
    CANCERS, 2018, 10 (12):
  • [23] Notch-4 is a novel therapeutic target and prognostic marker for triple negative breast cancer
    Kai, M.
    Mori, H.
    Yamada, M.
    Kubo, M.
    Nakamura, M.
    BREAST, 2017, 32 : S96 - S96
  • [24] ERRβ: Validating a novel target for triple negative breast cancer
    Fernandez, Aileen I.
    Graham, Garrett
    Gyorffy, Balazs
    Cavalli, Luciane
    Riggins, Rebecca B.
    CANCER RESEARCH, 2017, 77
  • [25] Mesothelin, a novel immunotherapy target for triple negative breast cancer
    Tchou, Julia
    Wang, Liang-Chuan
    Selven, Ben
    Zhang, Hongtao
    Conejo-Garcia, Jose
    Borghaei, Hossein
    Kalos, Michael
    Vondeheide, Robert H.
    Albelda, Steven M.
    June, Carl H.
    Zhang, Paul J.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 799 - 804
  • [26] Mesothelin, a novel immunotherapy target for triple negative breast cancer
    Julia Tchou
    Liang-Chuan Wang
    Ben Selven
    Hongtao Zhang
    Jose Conejo-Garcia
    Hossein Borghaei
    Michael Kalos
    Robert H. Vondeheide
    Steven M. Albelda
    Carl H. June
    Paul J. Zhang
    Breast Cancer Research and Treatment, 2012, 133 : 799 - 804
  • [27] WNT PATHWAY AS THERAPEUTIC TARGET OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Huelsewig, C.
    Goette, M.
    Ruckert, C.
    Buchweitz, O.
    Kiesel, L.
    Pusztai, L.
    Liedtke, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 39 - 39
  • [28] Mitochondrial dynamics, a new therapeutic target for Triple Negative Breast Cancer
    Weiner-Gorzel, K.
    Murphy, M.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1875 (02):
  • [29] Ceritinib is a novel triple negative breast cancer therapeutic agent
    Dong, Shengli
    Yousefi, Hassan
    Van Savage, Isabella
    Okpechi, Samuel C.
    Wright, Maryl K.
    Matossian, Margarite D.
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    Alahari, Suresh K.
    MOLECULAR CANCER, 2022, 21 (01)
  • [30] Ceritinib is a novel triple negative breast cancer therapeutic agent
    Shengli Dong
    Hassan Yousefi
    Isabella Van Savage
    Samuel C. Okpechi
    Maryl K. Wright
    Margarite D. Matossian
    Bridgette M. Collins-Burow
    Matthew E. Burow
    Suresh K. Alahari
    Molecular Cancer, 21
12345